News Focus
News Focus
icon url

skitahoe

12/22/23 6:17 PM

#658473 RE: biosectinvestor #658468

We'll have to agree to disagree, unless there is a partnership prior, I just don't see where NWBO can afford the costs of building the facilities you describe. It's not that the EDEN units are that expensive, but all the rest, especially the cryogenics and facilities needed to distribute the vaccine that's needed, potentially for a number of years for each patient, will be a very expensive proposition that already exists with the likes of CRL and Advent, but they'd have to build from scratch themselves.

I believe agreements, which will use the EDEN's, already exist, but must be dated, signed and sealed. Of course I could be wrong about that. I believe that their patent protections are strong, as is their agreement with St. Gobain's to make the disposable cassettes. I won't say they couldn't be ripped off, but it would clearly violate their patents and could cost more than purchasing from NWBO.

I previously said that FlaskWorks could become a profit center for NWBO. I believe it can build devices similar to the EDEN for other personalized products that have other companies paying NWBO for this equipment. NWBO would be paid by those using FlaskWork equipment rather than attempting to duplicate it without violating their patents.

Gary
Bullish
Bullish
icon url

attilathehunt

12/23/23 12:17 AM

#658553 RE: biosectinvestor #658468

"They may disperse that centralized facility, but they will need to keep careful control over that process or they will never be licensed"

I often wonder if the $3M we received several months ago was a good faith deposit from Merck for assistance in helping them set up their West Point facility?

We are still owed details for that transaction and I sense it may have to do with a partnership license...If so, we should soon find out.